Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HF Foods Group Inc.HFFG · Entity 6754 | CFO | June 01, 2026 | June 03, 2026 |
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | SVP, Finance and CAO | March 17, 2023 | March 21, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HF Foods Group Inc.
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 63,787 |
Reported balance
After 2026-06-01 transaction · row 1
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 54,087 · Balance 63,787 F1: Represents a grant of restricted stock units; vests in one-third increments annually, beginning April 15, 2027. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,287 |
Reported balance
After 2026-06-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-01 · Grant · Acquired 54,087 · Balance 61,287 F2: Each performance stock unit ("PSU") represents a contingent right to receive 1 to 2.25x shares of the Issuer's Class A Common Stock upon satisfaction of applicable vesting conditions. F3: The PSUs are scheduled to vest on April 15, 2029, if for at least a period of thirty trading days commencing on January 1, 2026, and ending on December 31, 2028, the closing market capitalization of the Issuer averages $200 million to $400 million over such thirty-day period. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock units; vests in one-third increments annually, beginning April 15, 2027.
F2: Each performance stock unit ("PSU") represents a contingent right to receive 1 to 2.25x shares of the Issuer's Class A Common Stock upon satisfaction of applicable vesting conditions.
F3: The PSUs are scheduled to vest on April 15, 2029, if for at least a period of thirty trading days commencing on January 1, 2026, and ending on December 31, 2028, the closing market capitalization of the Issuer averages $200 million to $400 million over such thirty-day period.
ROCKWELL MEDICAL, INC.
Report date March 17, 2023 · Filed March 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,515 |
Reported balance
After 2023-03-17 transaction · row 1
1 source rowRow 1 · 2023-03-17 · Grant · Acquired 28,515 · Balance 28,515 F1: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.37 · Expires 2033-03-17 | Direct | 37,210 |
Reported balance
After 2023-03-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-17 · Grant · Acquired 37,210 · Balance 37,210 F2: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
F2: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 20:55 UTC | HF Foods Group Inc. HFFG · Entity 6754 | GrantPerformance Stock Units · Derivative | 54,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001780044-26-000005 · wk-form4_1780520099.xml · derivative · entry 2 McGarry Paul E · CIK 0001780044 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,287 Underlying: Common Stock · 54,087 shares Expires not disclosed F2 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive 1 to 2.25x shares of the Issuer's Class A Common Stock upon satisfaction of applicable vesting conditions. F3 · derivative.exercise_date: The PSUs are scheduled to vest on April 15, 2029, if for at least a period of thirty trading days commencing on January 1, 2026, and ending on December 31, 2028, the closing market capitalization of the Issuer averages $200 million to $400 million over such thirty-day period. F3 · derivative.expiration_date: The PSUs are scheduled to vest on April 15, 2029, if for at least a period of thirty trading days commencing on January 1, 2026, and ending on December 31, 2028, the closing market capitalization of the Issuer averages $200 million to $400 million over such thirty-day period. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:55 UTC | HF Foods Group Inc. HFFG · Entity 6754 | GrantCommon Stock | 54,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001780044-26-000005 · wk-form4_1780520099.xml · nonDerivative · entry 1 McGarry Paul E · CIK 0001780044 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,787 F1 · price: Represents a grant of restricted stock units; vests in one-third increments annually, beginning April 15, 2027. Read SEC document |
| March 18, 2026 Filed Mar 18, 2026 17:57 UTC | HF Foods Group Inc. HFFG · Entity 6754 | PurchaseCommon Stock | 2,500 | $1.76 | $4,400.00 |
DisclosureSEC source: 0001780044-26-000002 · wk-form4_1773856620.xml · nonDerivative · entry 1 McGarry Paul E · CIK 0001780044 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,700 Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:33 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 37,210 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001104659-23-035187 · tm2310125-2_4seq1.xml · derivative · entry 2 McGarry Paul E · CIK 0001780044 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,210 Underlying: Common Stock · 37,210 shares Expires 2033-03-17 F2 · derivative.exercise_date: Stock options vest 25% on the first anniversary of March 17, 2023, with the remainder vesting in equal monthly installments through March 17, 2027, subject to the Reporting Person's continued service to the Issuer. Stock options are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 22:33 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 28,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035187 · tm2310125-2_4seq1.xml · nonDerivative · entry 1 McGarry Paul E · CIK 0001780044 · SVP, Finance and CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,515 F1 · kind: Restricted stock units ("RSUs") vest in two equal installments on the first and second anniversaries of March 17, 2023, subject to the Reporting Person's continued service to the Issuer. RSUs are also subject to stockholder approval of an increase in the share reserve under the Rockwell Medical, Inc. Amended and Restated 2018 Long Term Incentive Plan at the 2023 annual meeting of stockholders. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:31 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001104659-22-099658 · tm2225800-2_4seq1.xml · derivative · entry 1 McGarry Paul E · CIK 0001780044 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2032-09-09 F1 · derivative.exercise_date: Stock options vest in four equal installments on the first, second, third and fourth anniversaries of September 9, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| May 03, 2021 Filed Jun 3, 2021 20:49 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001628280-21-011602 · wf-form4_162275335423246.xml · derivative · entry 1 McGarry Paul E · CIK 0001780044 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:18 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.04 | $0.00 |
DisclosureSEC source: 0001628280-20-009345 · wf-form4_159199306704678.xml · derivative · entry 1 McGarry Paul E · CIK 0001780044 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: Stock options vest in three equal installments on the first, second and third anniversaries of June 11, 2020, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 20:11 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001104659-19-037653 · a4.xml · derivative · entry 1 McGarry Paul E · CIK 0001780044 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-06-24 F1 · derivative.exercise_date: Stock options vest in three equal installments on the first, second and third anniversaries of June 24, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.